MC
IDXX icon

Moors & Cabot’s Idexx Laboratories IDXX Stock Holding History

Moors & Cabot’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-425
Closed -$288K – 958
2025
Q4 		$288K Hold
425
– – 0.01% 707
2025
Q3 		$272K Hold
425
– – 0.01% 711
2025
Q2 		$228K Buy
+425
New +$203K 0.01% 753
2024
Q4 		– Sell
-415
Closed -$210K – 906
2024
Q3 		$210K Buy
+415
New +$202K 0.01% 780
2023
Q2 		– Sell
-1,146
Closed -$573K – 879
2023
Q1 		$573K Hold
1,146
– – 0.04% 400
2022
Q4 		$468K Sell
1,146
-15
-1% -$5.82K 0.03% 444
2022
Q3 		$378K Sell
1,161
-171
-13% -$62.8K 0.03% 484
2022
Q2 		$467K Sell
1,332
-425
-24% -$173K 0.03% 432
2022
Q1 		$961K Buy
1,757
+52
+3% +$27.4K 0.06% 302
2021
Q4 		$1.12M Sell
1,705
-210
-11% -$132K 0.07% 260
2021
Q3 		$1.19M Buy
1,915
+156
+9% +$105K 0.08% 244
2021
Q2 		$1.11M Sell
1,759
-30
-2% -$16.6K 0.08% 246
2021
Q1 		$877K Sell
1,789
-1,910
-52% -$957K 0.07% 268
2020
Q4 		$1.85M Sell
3,699
-193
-5% -$86.4K 0.16% 142
2020
Q3 		$1.53M Sell
3,892
-320
-8% -$118K 0.14% 149
2020
Q2 		$1.39M Sell
4,212
-106
-2% -$30.7K 0.15% 149
2020
Q1 		$1.04M Sell
4,318
-351
-8% -$91.6K 0.15% 144
2019
Q4 		$1.22M Sell
4,669
-353
-7% -$93K 0.12% 177
2019
Q3 		$1.36M Buy
5,022
+315
+7% +$87.7K 0.15% 149
2019
Q2 		$1.3M Buy
4,707
+1,237
+36% +$305K 0.16% 144
2019
Q1 		$774K Buy
3,470
+150
+5% +$31K 0.11% 205
2018
Q4 		$618K Sell
3,320
-100
-3% -$20.5K 0.1% 217
2018
Q3 		$852K Buy
3,420
+620
+22% +$151K 0.1% 218
2018
Q2 		$611K Buy
2,800
+345
+14% +$71.1K 0.08% 264
2018
Q1 		$470K Buy
+2,455
New +$453K 0.06% 341

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moors & Cabot's IDXX Position: Q1 2026 in Review

Moors & Cabot sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 425 shares — an estimated $288K sold.

Moors & Cabot first reported a position in IDXX in Q1 2018 and held it in 25 quarters. The position peaked at $1.85M in Q4 2020. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Moors & Cabot reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Moors & Cabot sold 425 Idexx Laboratories shares in Q1 2026, an estimated $288K.
  • Moors & Cabot first reported a position in Idexx Laboratories in Q1 2018 and held it in 25 quarters.
  • Moors & Cabot's Idexx Laboratories position peaked at $1.85M in Q4 2020.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.